Posted by Michael Wonder on 02 Oct 2021
The U.S. can lower drug prices without sacrificing innovation
1 October 2021 - Legislation giving Medicare the ability to negotiate drug prices in the United States would make their life saving potential immediately available to millions of Americans who cannot now afford them, thus extending lives and alleviating suffering.
The pharmaceutical industry, however, has done a masterful job of arguing that these Americans must suffer in the short term since lower prices would gut long-term innovation in drug development.
This is a false choice. We need not trade the certainty of saved lives now for the possibility of saved lives in the future.
